| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 29 Apr 2025 | 21 Apr 2025 |
| Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2025 inter alia to consider and approve Audited Financial Results for the quarter and financial year ended 31st March 2025 The Board on meeting held today on 29th April 2025 has approved the following. 1. Standalone Audited Financial Results as on 31st March 2025 along with Auditors Report 2. Consolidated Audited Financial Results as on 31st March 2025 along with Auditors Report 3. Other Disclosure/ Announcements. (As Per BSE Announcement dated on 29.04.2025) | ||
| Board Meeting | 23 Jan 2025 | 15 Jan 2025 |
| Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2025 inter alia to consider and approve unaudited financial results for the period ended 31st December 2024 Nath Bio-Genes (India) Ltd has informed BSE regarding Outcome of Board Meeting held on January 23, 2025. (As Per BSE Announcement Dated on: 23/01/2025) | ||
| Board Meeting | 23 Oct 2024 | 17 Oct 2024 |
| Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2024 inter alia to consider and approve unaudited financial results for the quarter and half year ended 30th September 2024. Outcome of Board Meeting (As Per BSE Announcement Dated on: 23/10/2024) | ||
| Board Meeting | 7 Aug 2024 | 30 Jul 2024 |
| Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2024 inter alia to consider and approve Unaudited financial results as on 30th June 2024. Unaudited financial results as at 30th June 2024. (As Per BSE Announcement dated on 07.08.2024) | ||
| Board Meeting | 8 May 2024 | 30 Apr 2024 |
| Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2024 ,inter alia, to consider and approve Audited Financial Results for the year ended 31st March 2024. Outcome of Board meeting held on 08th May 2024 for approval of 1. Audited Financial Results as on 31st March 2024. 2. Recommendation of Dividend by Board of Directors 3. Date of Annual General Meeting of the Company for financial year 2023-24 Outcome of Board Meeting of the Company held on 08th May 2024. Outcome of Board meeting held on 08th May 2024 for approval of 1. Audited Financial Results as on 31st March 2024. 2. Recommendation of Dividend by Board of Directors 3. Date of Annual General Meeting of the Company for financial year 2023-24 (As Per BSE Announcement Dated on 08.05.2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
